Abstract
The misfolding, aggregation and accumulation of proteins in the brain, represents a common feature of diverse neurodegenerative diseases among which Alzheimers disease (AD). Important therapeutic strategies for this pathology aim at inhibiting the aggregation of misfolded amyloid β (Aβ) peptides into different species, particularly intermediate oligomeric assemblies, which are believed to be the most neurotoxic species. Here we review the structural data present in the literature, with the purpose to supply useful information for the rational design of new potential molecules able to target Aβ peptides and fibrils. In particular, structural information concerning the different Aβ peptides assemblies, their supramolecular organization, their interaction with cations, biological membranes and known ligands are reported.
Keywords: neurodegenerative disease, biological membrane, heart disease, intermediate oligomeric assemblies, aggregates, β-amyloid, Aβ oligomers, Aβ fibrils, Aβ peptide structural features, Alzheimers's disease
Current Bioactive Compounds
Title: Aβ Monomers, Oligomers and Fibrils: Structural Features
Volume: 7 Issue: 3
Author(s): Cristina Airoldi, Erika Sironi, Barbara La Ferla, Francisco Cardona and Francesco Nicotra
Affiliation:
Keywords: neurodegenerative disease, biological membrane, heart disease, intermediate oligomeric assemblies, aggregates, β-amyloid, Aβ oligomers, Aβ fibrils, Aβ peptide structural features, Alzheimers's disease
Abstract: The misfolding, aggregation and accumulation of proteins in the brain, represents a common feature of diverse neurodegenerative diseases among which Alzheimers disease (AD). Important therapeutic strategies for this pathology aim at inhibiting the aggregation of misfolded amyloid β (Aβ) peptides into different species, particularly intermediate oligomeric assemblies, which are believed to be the most neurotoxic species. Here we review the structural data present in the literature, with the purpose to supply useful information for the rational design of new potential molecules able to target Aβ peptides and fibrils. In particular, structural information concerning the different Aβ peptides assemblies, their supramolecular organization, their interaction with cations, biological membranes and known ligands are reported.
Export Options
About this article
Cite this article as:
Airoldi Cristina, Sironi Erika, La Ferla Barbara, Cardona Francisco and Nicotra Francesco, Aβ Monomers, Oligomers and Fibrils: Structural Features, Current Bioactive Compounds 2011; 7 (3) . https://dx.doi.org/10.2174/157340711796817896
DOI https://dx.doi.org/10.2174/157340711796817896 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Unconventional Players on the Striated Muscle Field: microRNAs, Signaling Pathways and Epigenetic Regulators
Current Stem Cell Research & Therapy Peroxisome Proliferator-Activated Receptor γ Agonists as Insulin Sensitizers: From the Discovery to Recent Progress
Current Topics in Medicinal Chemistry Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice
Current Pharmaceutical Biotechnology Cannabinoids: Occurrence and Medicinal Chemistry
Current Medicinal Chemistry Gender Differences in the Clinical Presentation of Heart Disease
Current Pharmaceutical Design Inhibition of Tumor Angiogenesis by Antibodies, Synthetic Small Molecules and Natural Products
Current Medicinal Chemistry Secondary Hypertension: The Ways of Management
Current Vascular Pharmacology Cardiac Regeneration: Stem Cells and Beyond
Current Medicinal Chemistry Diabetic Cardiomyopathy and its Prevention by Metallothionein: Experimental Evidence, Possible Mechanisms and Clinical Implications
Current Medicinal Chemistry Cardiac Stem Cell-Based Myocardial Regeneration: Towards a Translational Approach
Cardiovascular & Hematological Agents in Medicinal Chemistry Cardioprotective Effects of Natural Products <i>via</i> the Nrf2 Signaling Pathway
Current Vascular Pharmacology Targeted Therapy Options for Treatment of Bone Metastases; Beyond Bisphosphonates
Current Pharmaceutical Design Taurine, Bone Growth and Bone Development
Current Nutrition & Food Science Is Helicobacter pylori the Infectious Trigger for Headache?: A Review
Infectious Disorders - Drug Targets Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Focus on Virus Induced Exacerbations
Current Pharmaceutical Design The Many Antithrombotic Actions of Nitric Oxide
Current Drug Targets Transcription Factors in Heart: Promising Therapeutic Targets in Cardiac Hypertrophy
Current Cardiology Reviews Liver Enzymes: Potential Cardiovascular Risk Markers?
Current Pharmaceutical Design Pain-Relief Medication and Risk of Fractures
Current Drug Safety The Promises and Challenges of the Use of Genomics in the Prescription of Exercise for Hypertension: The 2013 Update
Current Hypertension Reviews